Monte Rosa Therapeutics GLUE
NASDAQ GLUE
$11.26 -0.67 (-5.62%)
At close: Oct 1, 2026 · 4:00 PM EDT

Monte Rosa Therapeutics (GLUE) EV to FCF (2024 - 2025)

Updated

Monte Rosa Therapeutics' (GLUE) EV to FCF stood at 2.77 in Q3 2025, down 78.0% from the prior quarter.

Analysis

Monte Rosa Therapeutics (GLUE) EV to FCF (2024 - 2025) Analysis & Trends

On a TTM basis, Monte Rosa Therapeutics' EV to FCF came in at 0.21 as of Sep 30, 2025; for FY2024, it was 5.33.

  • Per Business Quant, the preceding three quarters came in at 12.63 (Q2 2025), 9.93 (Q1 2025) and 5.33 (Q4 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Monte Rosa Therapeutics 1.02 Bn 428.56 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 2.77
Jun 30, 2025 12.63
Mar 31, 2025 9.93
Dec 31, 2024 5.33
API Access

Monte Rosa Therapeutics EV to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-fcf&ticker=GLUE&period=max&api_key=YOUR_API_KEY